Help your practice thrive—one week at a time.

Welcome to The Practice Brief, your weekly roundup of the news, trends, and ideas shaping the future of dermatology. Each edition highlights the biggest developments in practice management, reimbursement, policy, AI, business, and professional growth, while connecting them to existing Dermatology Times and NP/PA Connect coverage. The goal isn't just to keep you informed—it's to help you discover what's next, identify opportunities, and keep your practice performing at its best.

The Physician Down the Hall Doesn't Cover Your Incident-To Billing

If your National Provider Identifier appears on a claim, the liability is yours, not your billing department's and not your practice's. That principle underlies a wave of federal dermatology enforcement, including a case in which agents executed search warrants across every location of a multisite practice that had already paid $6.6 million to settle a prior False Claims Act allegation. Incident-to billing lets an NP or PA visit go out under a supervising physician's NPI at 100% of the fee schedule instead of 85%, but only if the physician personally evaluated the patient for that specific condition, made the diagnosis, and built the plan of care first. The physician being down the hall does not satisfy that requirement.¹

Two Tennessee physicians paid $341,690 after NPs were billed at the physician rate without a qualifying initiating visit, including while the physicians were traveling abroad. Mohs billing carries its own rigid rule: the surgeon who excises the tissue must also read the pathology, and a multisite Southeast practice settled for $6.6 million when that line was crossed. Upcoding is just as costly. A Florida practice paid $847,394 after a physician whistleblower alleged linear repairs were billed as flaps.¹

The supervising physician must be immediately available via 2-way audio-video throughout the encounter. Phone only or absence from the clinic does not qualify. — Faith C. McNicholas, RHIT, CPC, CPCD, PCS, CDC, American Academy of Dermatology

▶ Why it matters: Audit your own incident-to visits and Mohs pathology workflow before a payer or the OIG does it for you.

New York Buys NPs 4 More Years of Independent Practice

Gov. Kathy Hochul extended New York's independent practice authority for qualified NPs through July 1, 2030, moving the sunset date 4 years past its original July 1, 2026 expiration. NPs who have completed at least 3600 hours of practice can continue treating patients within their certified specialty without a written physician practice agreement or collaborative protocol. NPs below that threshold still need a formal collaborative arrangement with a physician in the relevant specialty, and the extension does not change that requirement or add new registration steps.²

Companion bills S2360 and A1220 would eliminate the sunset provision entirely and let NPs who have not reached 3600 hours collaborate with an experienced NP instead of a physician. Neither bill had passed as of July 2026, so the current framework holds through 2030 regardless of what happens next legislative session.²

I am absolutely thrilled with the extension of independent practice authority in New York! — Lakshi Aldredge, MSN, ANP-BC, DCNP

▶ Why it matters: If you're below the 3600-hour threshold, your collaboration requirement hasn't changed. Track your hours precisely.

Dermatology Is Payers' Favorite Target for Automated Denials

Thirteen major payers now run automated denial programs targeting E/M claims, and one large Northeast Blue Cross Blue Shield affiliate recently moved from paying reduced E/M rates to denying claims outright, demanding records within a 1-week window before releasing payment. Modifier 25 appears on 61.5% of dermatology E/M claims, roughly 4 times the specialty average, which puts every dermatology practice in the crosshairs of payer claim-editing algorithms even though a November 2025 OIG audit found 90% compliance among the claims reviewed.³

The economics favor practices that push back. More than 80% of prior authorization appeals succeed, and a 2018 OIG report found Medicare Advantage plans overturned 75% of their own denials on appeal. Fewer than 1% of denied claims are ever appealed. Real-time eligibility verification, a weekly denial huddle tracking the top 3 denial reasons by dollar volume, and state Department of Insurance complaints for fully insured plans are among the concrete steps practices can take starting this week.³

▶ Why it matters: If you're not appealing denials, the data says you're likely leaving money on the table you'd win back.

AI Can Now Score Eczema Severity From an Ordinary Smartphone Photo

A prospective study across 16 Japanese institutions trained a ConvNeXt convolutional neural network on 3676 uncropped smartphone images from 1016 adults with atopic dermatitis, scoring erythema, papulation/edema, excoriation, and lichenification against dermatologist-consensus grades. For detecting an EASI component severity of 2 or higher, the model reached an area under the curve of 0.825 to 0.860 across the 4 signs, with erythema performing best and papulation/edema performing worst, likely because raised, 3-dimensional lesions are harder to judge from a flat image.⁴

Accuracy climbed further at the most severe threshold, with AUC values above 0.900 for all 4 signs. The authors built the tool for training and standardizing raters, not clinical decision-making, and the dataset's Japanese-only population means performance in other skin phototypes remains uncertain. The model also cannot calculate a total EASI score because it does not estimate affected body surface area.⁴

▶ Why it matters: This is a rater-training aid for now, not a diagnostic tool. Don't score patients with it yet, but expect training uses soon.

Allergan Aesthetics Rewrites Its Loyalty Program Around Total Portfolio Volume

Allergan Aesthetics updated Allergan Partner Privileges with new Portfolio Levels that reward total purchasing volume across injectables, body contouring, plastic surgery, and skin care rather than single product categories, potentially letting practices reach higher discount tiers faster. Net pricing now displays at order entry, and practices can track their status and progress toward the next tier in real time. A new BOTOX Cosmetic Growth Benefit adds a quarterly rebate for practices hitting qualifying growth targets, on top of standard APP savings.⁵

The refresh comes as GLP-1 use reshapes aesthetic practices. Allergan data presented at the 2026 American Academy of Dermatology meeting found practices saw roughly 137% growth in patients on GLP-1 agonists between 2023 and 2024, with 32% of those patients new to aesthetic care, even as 82% of providers cited cost as a barrier to treatment. Allergan said the changes respond to practices wanting “greater simplicity, more transparency and rewards” that match how their businesses grow.⁵

▶ Why it matters: If your practice buys across multiple Allergan categories, your APP tier may climb faster under the new portfolio math.

References:

1. Gatti J. Your name is on the claim: billing compliance, federal enforcement, and why the provider always pays. Dermatology Times. Published August 3, 2026. Accessed August 19, 2026. https://www.dermatologytimes.com/view/your-name-is-on-the-claim-billing-compliance-federal-enforcement-and-why-the-provider-always-pays
2. Heaning S. New York extends nurse practitioner independent practice authority through 2030. Dermatology Times. Published July 16, 2026. Accessed August 19, 2026. https://www.dermatologytimes.com/view/new-york-extends-nurse-practitioner-independent-practice-authority-through-2030
3. Elias MJ, Krishnan A. The new economics of dermatology claims: understanding and responding to rising denials. Dermatology Times. Published June 23, 2026. Accessed August 19, 2026. https://www.dermatologytimes.com/view/the-new-economics-of-dermatology-claims-understanding-and-responding-to-rising-denials
4. Bosslett M. Smartphone-based AI tool shows high discriminative accuracy in evaluating EASI severity. Dermatology Times. Published August 14, 2026. Accessed August 19, 2026. https://www.dermatologytimes.com/view/smartphone-based-ai-tool-shows-high-discriminative-accuracy-in-evaluating-easi-severity
5. Heaning S. Allergan Aesthetics refreshes APP loyalty program for aesthetic practices. Dermatology Times. Published August 15, 2026. Accessed August 19, 2026. https://www.dermatologytimes.com/view/allergan-aesthetics-refreshes-app-loyalty-program-for-aesthetic-practices